Joseph Cobuzzi Robert's Insider Trades & SAST Disclosures
Joseph Cobuzzi Robert's most recent trade in CervoMed Inc was a trade of 27,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joseph Cobuzzi Robert.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CervoMed Inc | Robert Joseph Cobuzzi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 27,000 | 27,000 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Joseph Cobuzzi Robert | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 55,721 | 55,721 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 327 | 0 | - | - | Restricted Stock Unit | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 327 | 1,737 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jan 2023 | 121 | 1,616 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2022 | 327 | 1,531 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2022 | 327 | 327 | - | - | Restricted Stock Unit | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2022 | 121 | 1,410 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 327 | 654 | - | - | Restricted Stock Unit | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 327 | 1,325 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2022 | 121 | 1,204 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2022 | 327 | 1,119 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2022 | 327 | 981 | - | - | Restricted Stock Unit | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 May 2022 | 121 | 998 (0%) | 0% | - | Common Sock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | 18 Apr 2022 | 100 | 0 | - | - | Series C Convertible Preferred Stock | ||
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | 18 Apr 2022 | 100 | 792 (0%) | 0% | 25 | 2,500 | Common Stock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Mar 2022 | 5,000 | 5,000 | - | - | Series C Convertible Preferred Stock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 16,350 | 65,400 | - | - | Restricted Stock Unit | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 16,350 | 40,651 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jan 2022 | 6,049 | 34,602 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 764,357 | 764,357 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 161,139 | 161,139 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 53,713 | 53,713 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2020 | 475,000 | 475,000 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Robert Joseph Cobuzzi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 61,300 | 61,300 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges